Compare Canadian Pacific Kansas City Limited Common Shares (CP) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Pacific Kansas City Limited Common Shares vs ImmunityBio Inc. Common Stock — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $84.56 (market cap $73.98B), while ImmunityBio Inc. Common Stock trades at $10.53 (market cap $10.51B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 7× ImmunityBio Inc. Common Stock's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.9% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals.
| CP | IBRX | |
|---|---|---|
Market Cap | $73.98B | $10.51B |
Volume | 1,669,828 | 10,445,785 |
Sector | Industrials | Health |
52-Week High | $96.69 | $11.55 |
52-Week Low | $68.88 | $1.98 |
Enterprise Value | $91.36B | $10.97B |
Dividend Yield | 0.9% | — |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canadian Pacific Kansas City Limited Common Shares
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
